Molbank (Oct 2023)

Potassium 6-Oxo-7,13,16,22-tetraazatetracyclo[12.6.2.1<sup>8,12</sup>.0<sup>17,21</sup>]tricosa-1(20),8(23),9,11,14,16,18,21-octaen-2-yne-15-carboxylate

  • Camille Blouet,
  • Stéphanie Letast,
  • Thomas Robert,
  • Stéphane Bach,
  • Noël Pinaud,
  • Nicolas Joubert,
  • Marie-Claude Viaud-Massuard,
  • Jean Guillon,
  • Cédric Logé,
  • Caroline Denevault-Sabourin

DOI
https://doi.org/10.3390/M1735
Journal volume & issue
Vol. 2023, no. 4
p. M1735

Abstract

Read online

Potassium 6-oxo-7,13,16,22-tetraazatetracyclo[12.6.2.18,12.017,21]tricosa-1(20),8(23),9,11,14,16,18,21-octaen-2-yne-15-carboxylate was synthesized through a multi-step pathway, starting from commercially available 3-iodo-1,2-phenylenediamine. Structure characterization of this new substituted macrocyclic quinoxaline compound was achieved using 1H NMR, 13C NMR, and HRMS spectral analysis. This new macrocyclic derivative demonstrated submicromolar potency on both Pim-1 and Pim-2 isoforms, with an interesting selectivity profile against a selected panel of human kinases.

Keywords